Cargando…
Substandard medicines: a greater problem than counterfeit medicines?
Autores principales: | Sammons, Helen M, Choonara, Imti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842987/ https://www.ncbi.nlm.nih.gov/pubmed/29637090 http://dx.doi.org/10.1136/bmjpo-2017-000007 |
Ejemplares similares
-
Substandard and counterfeit medicines: a systematic review of the literature
por: Almuzaini, Tariq, et al.
Publicado: (2013) -
Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013) -
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021) -
Quality of medicines in Canada: a retrospective review of risk communication documents (2005–2013)
por: Almuzaini, Tariq, et al.
Publicado: (2014) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
por: Khurelbat, Daariimaa, et al.
Publicado: (2020)